BioSpace News Archive

Sight Sciences, Inc. (Nasdaq: SGHT) an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced plans to participate in the upcoming Morgan Stanley Global Healthcare Conference in New York, NY.

A statewide coalition of public and private partner organizations and institutions, led by the North Carolina Biotechnology Center, has received a Phase 2 award totaling nearly $25 million from the U.S. Economic Development Administration’s Build Back Better Regional Challenge.

Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company using translational bioinformatics to advance a pipeline of product candidates designed to benefit large populations of patients with cancer and other diseases, today announced it submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA).

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Baird 2022 Global Healthcare Conference in New York City on Wednesday, September 14, 2022 at 2:35 p.m. ET.

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), announces that the company’s Current Good Manufacturing Practice (CGMP) manufacturing facility located at the Research Triangle Park (RTP) in North Carolina, the United States of America (“The RTP GMP Manufacturing Facility”) has started GMP production of autologous CAR T-cell products and successfully released the first GMP batch for the clinical trials.

PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced top-line results from the SHIELD I Phase 3 study of D-PLEX100 for the prevention of surgical site infections (SSIs) in abdominal surgery.

Neukio Biotherapeutics, a company committed to developing novel cell therapy products, announces it has closed $50 million in a Series A-1 funding round.

Lexaria Bioscience Corp., a global innovator in drug delivery platforms is pleased to announce that Catherine Turkel, PharmD, PhD has joined the board of directors of Lexaria Bioscience Corp.

In recognition of Peripheral Artery Disease (PAD) Awareness Month, Healogics® is empowering patients living with PAD, to seek timely wound care treatment critical for optimal healing and reducing the risk of amputations.

International medical imaging IT and cybersecurity company Sectra’s contracted order bookings amounted to SEK 2.2 billion during the quarter, which is the highest ever level for a single quarter.